Millets National Media Portal
Millets National Media Portal
Foxtail millet (Setaria italica), particularly in its fermented and germinated forms, demonstrates the most robust scientific evidence for alleviating colitis symptoms. A landmark study published in PMC investigated the effects of foxtail millet on dextran sulfate sodium (DSS)-induced murine colitis and found that fermented-germinated foxtail millet flour (FG-FM) almost completely reversed DSS-induced gut microbiota dysbiosis.
Evidence for foxtail millet in colitis management:
Fermented-germinated foxtail millet (FG-FM): The most effective processing form — restored microbial diversity, reduced disease activity index (DAI), and repaired intestinal epithelial barrier integrity in colitis models.
STAT3 pathway suppression: Foxtail millet's bioactive compounds suppress STAT3 — the molecular 'link between inflammation and cancer' in IBD — reducing both colitis severity and colorectal cancer risk.
Gut receptor activation: GPCR41, GPCR43, and aryl hydrocarbon receptor (AHR) — gut receptors that maintain intestinal epithelial barrier integrity — are enhanced by foxtail millet polyphenols.
Cytokine modulation: Millet quinic acid (a polyphenol) reduces pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) while increasing anti-inflammatory cytokines (IL-10, IL-4, IL-5) in colitis models (PMC, 2022).
Microbiome remodeling: Foxtail millet bran polyphenols remodel gut microbiome composition in DSS-induced colitis, suppressing pathogens and supporting beneficial bacteria (Frontiers in Nutrition, 2022).
Tight junction restoration: Millet bioactive compounds help restore intestinal tight junction proteins (ZO-1, occludin) disrupted in colitis — preventing bacterial translocation and systemic inflammation.
Dietary recommendation: For active colitis, well-cooked or fermented foxtail millet porridge is preferred over raw whole-grain preparations to maximize tolerability.
© 2023 - 2026 Millets News. All rights reserved.
